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Abstract
Background: This study sought to prospectively and directly compare three cardiovascular magnetic resonance
(CMR) viability parameters: inotropic reserve (IR) during low-dose dobutamine (LDD) administration, late gadolinium
enhancement transmurality (LGE) and thickness of the non-contrast-enhanced myocardial rim surrounding the scar
(RIM). These parameters were examined to evaluate their value as predictors of segmental left ventricular (LV)
functional recovery in patients with LV systolic dysfunction undergoing surgical or percutaneous revascularisation.
The second goal of the study was to determine the optimal LDD-CMR- and LGE-CMR-based predictor of significant
(≥ 5%) LVEF improvement 6 months after revascularisation.
Methods: In 46 patients with chronic coronary artery disease (CAD) (63 ± 10 years of age, LVEF 35 ± 8%), wall
motion and the above mentioned CMR parameters were evaluated before revascularisation. Wall motion and LGE
were repeatedly assessed 6 months after revascularisation. Logistic regression analysis models were created using
333 dysfunctional segments at rest.
Results: An LGE threshold value of 50% (LGE50) and a RIM threshold value of 4 mm (RIM4) produced the best
sensitivities and specificities for predicting segmental recovery. IR was superior to LGE50 for predicting segmental
recovery. When the areas under the ROC curves is compared, the combined viability prediction model (LGE50 + IR)
was significantly superior to IR alone in all analysed sets of segments, except the segments with an LGE from 26%
to 75% (p = 0.08). The RIM4 model was not superior to the LGE50 model. A myocardial segment was considered
viable if it had no LGE or had any LGE and produced IR during LDD stimulation. ROC analysis demonstrated that ≥
50% of viable segments from all dysfunctional and revascularised segments in a patient predict significant
improvement in LVEF with a 69% sensitivity and 70% specificity (AUC 0.7, p = 0.05). The cut-off of ≥ 3 viable
segments was a less useful predictor of significant global LV recovery.
Conclusions: LDD-CMR is superior to LGE-CMR as a predictor of segmental recovery. The advantage is greatest in
the segments with an LGE from 26% to 75%. The RIM cut-off value of 4 mm had no superiority over the LGE cut-
off value of 50% in predicting the segmental recovery. Patients with ≥ 50% of viable segments from all
dysfunctional and revascularised had a tendency to improve LVEF by ≥ 5% after revascularisation.
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Hibernating myocardium is normally defined as a viable
and dysfunctional myocardium that improves in func-
tion following revascularisation [1]. The revascularisa-
tion of the hibernating myocardium results in an
improvement of the regional and global left ventricular
(LV) systolic function [2], reverse remodelling [3,4],
increased survival [3] and a decrease in the composite
end-point of myocardial infarction (MI), heart failure
and unstable angina [5]. In contrast, patients with mini-
mal or no evidence of myocardial viability appear to
gain no benefit from revascularisation as compared to
medical therapy [3].
Recently, the results of a viability substudy of the
STICH (Surgical Treatment for Ischemic Heart Failure)
trial were published [6]. This substudy was the first mul-
ticentre, non-blinded, randomised viability trial con-
ducted to determine whether the presence of substantial
myocardial viability influenced the likelihood of benefit
from medical therapy plus coronary artery bypass graft
surgery (CABG), as compared with medical therapy
alone, in patients with CAD and LV dysfunction (LVEF ≤
35%). This study, in contrast to a previous meta-analysis
of the retrospective viability studies conducted by Allman
et al. [3], did not find a significant interaction between
myocardial viability status and medical treatment versus
surgical treatment with respect to the rates of death from
any cause or from cardiovascular causes or the rate of
death or hospitalisation for cardiovascular causes. The
conclusions regarding the optimal therapy for patients
with CAD and LV dysfunction that can be drawn from
the results of this viability substudy [6] are limited by a
number of factors that are discussed in detail by Bonow
et al. [6]. The viability analysis was based on identifying
and quantifying the extent of viable myocardium in a bin-
ary fashion as (either having or not having substantial
myocardial viability) by two different methods: single-
photon-emission computed tomography (SPECT) and
dobutamine echocardiography. The combination of the
two different tests and the binary viability assessment
fashion could be important limitations of this study. In
addition, the findings of this substudy do not necessarily
indicate that myocardial viability does not have a patho-
physiological importance in patients with CAD and LV
dysfunction. Instead, it is likely that some other variables
in the analysis (e.g., LV volumes and LVEF) are causally
determined by the extent of viable myocardium [6]. A
cardiovascular magnetic resonance (CMR) viability
assessment in this trial was not performed because of the
limited data regarding outcomes in patients with chronic
ischemic LV dysfunction studied by CMR.
Previous CMR studies have demonstrated that quanti-
fication of the transmural extent of LGE by CMR can
be used to predict the likelihood of a recovery of
myocardial function after revascularisation. However, in
non-transmural scars (1% to 75%), only an intermediate
likelihood of functional recovery (59.6% in LGE 1% to
25%, 41.8% in LGE 26% to 50% and 10.5% in LGE 51%
to 75%) was found [7]. When the LDD stimulation was
compared to scar imaging, LDD-CMR is superior to
LGE-CMR in predicting the recovery of function after
revascularisation [8]. This observation was most pro-
nounced in segments with 1% to 74% transmural infarc-
tion [8]. It has been suggested that even though LGE-
CMR depicts the area of myocardial fibrosis, it does not
assess the functional state of the surrounding (poten-
tially viable) myocardium, which can be normal, remo-
delled, hibernating, stunned or ischemic. Another small
study (15 patients) conducted by Bove et al. [9] con-
cluded that in segments with 1%-50% LGE transmural-
ity, an improvement in wall thickening after
revascularisation is better predicted by the response to
LDD prior to revascularisation than by LGE. Kuehl et al.
[10] suggested that the thickness of the non-contrast-
enhanced and potentially viable myocardial rim sur-
rounding the scar may be clinically useful for assessing
myocardial viability. The functional state of unenhanced
myocardial rim can be assessed using LDD-CMR,
whereas the critical thickness of the scar surrounding
unenhanced myocardial rim, which is needed to regain
contractility after revascularisation, seems to be clinically
useful in patients with an ischemic cardiomyopathy and
regional wall thinning. This hypothesis was elegantly
tested in 35 patients (LVEF 50 ± 11%) with chronic dys-
functional myocardium due to a chronic total occlusion
by Kirschbaum et al. [11]. The authors of this study
quantified IR using LDD-CMR in myocardial segments
stratified according to the LGE transmurality, end-dia-
stolic wall thickness and the thickness of the unen-
hanced rim and compared these with segmental wall
thickening 6 months after a successful percutaneous
coronary intervention (PCI). The results of this study
indicated that in segments with an intermediate LGE (i.
e., LGE transmurality between 25% and 75%), the mea-
surement of baseline contractility of the unenhanced
epicardial rim or simply baseline contractility of the wall
(the authors assume that scar tissue does not contract)
better identifies which segments maintain IR and
recover after revascularisation than the LGE transmural-
ity, end-diastolic wall thickness and the thickness of the
unenhanced rim. The Kirschbaum study confirms that
only the jeopardised dysfunctional myocardium of the
unenhanced rim may have IR during LDD and recover
after revascularisation; however, the normokinetic unen-
hanced rim has no IR and no recovery after successful
PCI. The study authors [11] do not propose a clinical
viability assessment algorithm. Thus, it remains unclear
whether the additional use of LDD-CMR besides LGE-
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determine only the rest function of the unenhanced rim
in order to assess the presence of viable tissue. Further-
more, the value of the combination of different viability
prediction parameters was not assessed in the aforemen-
tioned study.
All the aforementioned studies advance the concept
that a more comprehensive approach to defining viabi-
lity by CMR is warranted in clinical practice when the
recovery of LV function is the desired endpoint. Thus,
our primary goal was to prospectively and directly com-
pare IR during LDD-CMR with the RIM and LGE as
predictors of segmental functional recovery in patients
with LV systolic dysfunction undergoing surgical or per-
cutaneous revascularisation. In the current study, we
prospectively tested the hypothesis that the addition of
LDD-CMR and quantification of IR or additional mea-
surement of the RIM in segments with 1 to 75% LGE
would improve the predictive value for the recovery of
LV segmental function after revascularisation in patients
with ischemic LV dysfunction. To the best of our
knowledge, this comparison has not been studied in
patients undergoing either surgical or percutaneous
revascularisation. Thus, the comparisons have not been
made in a patient cohort that most accurately represents
real clinical practice. The second goal of this study was
to determine the optimal LDD-CMR- and LGE-CMR-
based predictor of significant (≥ 5%) LVEF improvement
6 months after revascularisation. Surprisingly, the com-
bined LDD-CMR- and LGE-CMR-based predictor of
significant improvement of global LVEF has not been
investigated thus far.
Methods
Patients and Study Design
A prospective evaluation of the different CMR para-
meters for predicting LV segmental and global func-
tional recovery was performed in 46 patients (63 ± 10
years old, 3 with previous CABG, 35 with three-vessel
disease, 3 with one-vessel disease) with LV systolic dys-
function (LVEF 35 ± 8%) before they underwent surgical
(n = 34) or percutaneous (n = 12) revascularisation.
Sixty patients without contraindications for CMR were
screened for the following inclusion criteria: (1) CAD (>
70% stenosis in one or more major epicardial vessels),
scheduled for a revascularisation procedure; (2) LVEF ≤
45%; (3) at least two adjacent segments with wall motion
abnormalities at rest; and (4) no infarction or revascu-
larisation within the last two months. Patients were
included in the study only after a successful and com-
plete coronary revascularisation. Of the 14 patients who
did not complete the study, 3 decided not to undergo
the repeated CMR scan or were lost during follow-up; 7
had significant periprocedural injury (new LGE zones on
repeated CMR scans and clinically proven periproce-
dural myocardial infarction (MI) or MI between both
scans); 3 had pacemakers or defibrillators implanted in
the period between the MR scans; and 1 was excluded
because of dilated cardiomyopathy with secondary CAD.
None of the patients were excluded from the study for
technical reasons or image quality.
The mean interval between CMR and revascularisation
was 12 ± 13 days, and none of the patients presented
clinical evidence of infarction during this period. The
mean interval between MI and the first CMR was 3.6
years. In 46 patients, the extent of regional contractility
and LGE were determined repeatedly by CMR 28 ± 4
weeks (6 months) after revascularisation.
The study was approved by the Lithuanian Bioethics
Committee (Nr. 17), and informed written consent was
obtained from each patient prior to inclusion in the
study.
CMR protocol
All the CMR examinations were performed using a 1.5
Tesla MR scanner (Avanto, Siemens Medical Solutions,
Erlangen, Germany) using prospective gating. Steady-
state free precession cine CMR was performed with
breath holding. Four-, 3- and 2-chamber views, as well
as a short axis stack covering the left ventricle every 8
mm without a gap, were acquired at rest and at the
after each dose of dobutamine (5 and 10 μg/kg/min)
(TE/TR/flip angle 1.22 ms/63 ms/65 degrees, FOV 250
mm, voxel size 1.9 × 1.3 × 8 mm, matrix size 109 ×
192). After revascularisation, only rest images were
acquired using the same technique.
Ten to fifteen minutes after infusing 0.15 mmol/kg of
the commercially available gadolinium-based contrast
agent (gadopentetate dimeglumine or gadodiamide), an
inversion recovery gradient-echo sequence (TE/TR/flip
angle 3.2 ms/700 ms/25 degrees, FOV 400 mm, matrix
size 156 × 256) was performed in the same planes as
the cine images with an inversion time (240 to 330 ms)
chosen to reduce the signal from normal myocardium.
The typical voxel size was 2.1 × 1.6 × 8 mm. Angulation
was kept constant for a short-axis and LGE imaging to
enable a match between the LGE and wall motion
images.
Post-processing Analysis
We analysed the cine images and contrast-enhanced
images using a model in which the LV was divided into 17
segments [12]. The wall motion was graded as 1 (normal),
2 (mild hypokinesia), 3 (severe hypokinesia), 4 (akinesia)
or 5 (dyskinesia) by 2 blinded investigators. Discordant
assessments were jointly reviewed. For the patients under-
going percutaneous revascularisation, segments were con-
sidered to be undergoing revascularisation according to
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ment was assigned to a specific coronary artery territory
according to the vessel anatomy on a conventional angio-
gram. For the global LV functional analysis, all short-axis
slices from the base to the apex at rest and during admin-
istration of dobutamine (10 μg/kg/min) were analysed
with Argus software (Siemens) by two independent experi-
enced observers. The wall motion score index (WMSI)
was calculated by dividing the sum of scores by the num-
ber of segments per patient. The LV sphericity index (SI)
was measured by dividing the length of the LV from the
apex to the mitral annulus by the width of the LV at the
basal aspect of the papillary muscles in the end-diastolic
apical four-chamber view. An absolute change in LVEF ≥
5% 6 months after revascularisation was considered to be
significant. When predicting significant LVEF improve-
ment, a segment was considered viable if it had no LGE or
had any LGE and produced IR during LDD stimulation.
The number of viable segments divided by the total num-
ber of dysfunctional and revascularised segments in the
patient was expressed as a percentage that was used
together with the absolute number of viable segments to
predict significant LVEF improvement. We compared two
groups: responders (i.e., patients with significant LVEF
improvement 6 months after revascularisation) and non-
responders (i.e., patients without significant LVEF
improvement (improvement of LVEF < 5%)).
The extent of LGE within each segment and the RIM
were also measured by the two independent experienced
investigators on short-axis, contrast enhanced CMR
images. Contrast enhanced pixels were defined as those
with image intensities > 2 SD above the mean of image
intensities in a remote myocardial region in the same
image. LGE was assessed on a 5-grade scale [7] and ana-
lysed quantitatively by dividing the hyperenhanced area,
as measured by computer-assisted tracings, by the total
area in each segment before being expressed as a per-
centage. The thickness of the unenhanced rim was
defined as the mean wall thickness of the nonenhanced
area of a segment. Only the dysfunctional segments
detected on the first MR scan and those without an
increase in the LGE area on the second MR scan were
analysed. To calculate the mass of the LGE, we assumed
a specific gravity of 1.05 g/cm
3. Interobserver variability
for the transmural grading was checked for 10 patients
by 2 blinded experienced observers. The observers had a
good level of agreement (kappa = 0.88). The total LGE
score per patient was calculated by dividing sum of the
LGE scores by the number of segments.
An improvement in wall motion at follow-up by at
least 1 grade with the exception of improvement from
grade 5 to grade 4 was regarded as functional recovery
or viability of the segment. The LDD-CMR was
regarded as indicative of viability or IR when there was
an improvement of 1 wall motion grade at either the 5
or 10 μg/kg/min dose. All reviewers of the segmental
wall motion, LDD-CMR, LGE and functional recovery
were blinded to each other and to the clinical data of
the patients. All discordant assessments were jointly
reviewed.
Statistical analysis
To compare the values of different CMR parameters
for predicting segmental functional recovery, the usual
characteristics, such as sensitivity, specificity, positive
predictive value (PPV) and negative predictive value
(NPV) were calculated. Using a logistic regression
model, we identified the threshold values that pro-
duced the optimal sensitivities and specificities. Being
optimal did not mean that this threshold produced the
highest accuracy. The difference between sensitivity
and specificity was also considered (e.g., a threshold
producing 99% sensitivity and 10% specificity was not
treated as the best, even if its accuracy was the high-
est). Furthermore, we built several logistic regression
models to predict myocardial viability using IR, LGE50
and RIM4 values. For LGE50 and RIM4, the calcula-
tions were performed using binary variables, which
were assigned a value of 1 if the measurement
exceeded a threshold value and a value of 0 otherwise
(e.g., LGE50 = 1 when LGE > 50 and LGE50 = 0 when
LGE ≤ 50). As we wanted not only to test whether sin-
gle parameters perform differently but also to find out
whether there is rationale for using a combination of
several methods, 5 different logistic regression models
were created. In all of the viability models, functional
improvement after revascularisation acted as a depen-
dent variable. Meanwhile, the other above-mentioned
CMR parameters acted as independent variables. All
independent variables were statistically significant. To
find out which method had the best predictive ability,
we measured the areas under the receiver operating
curves (ROC) of the five different logistic regression
models.
The different baseline and follow-up characteristics of
patients with and without significant improvement in
LVEF 6 months after revascularisation were compared.
The values from both patient groups were expressed as
mean ± SD. The effect of revascularisation was com-
pared using a Wilcoxon signed-rank test. The continu-
ous variables that were not distributed normally were
compared by using a nonparametric test. The variables
that differed significantly between groups were included
in a forward stepwise (Wald) logistic regression analysis
to determine the best independent predictor of signifi-
cant LVEF improvement. The ROC analysis was per-
formed to validate the variables with the best predictive
ability. The predictor of global functional recovery was
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the ROC curve (AUC) was significantly greater.
All calculations were performed using SPSS 16.0 and
StAR [14] software. A p-value < 0.05 was considered
statistically significant.
Results
Forty-six patients underwent a successful and complete
revascularisation procedure. A significant improvement in
LVEF ≥ 5% was demonstrated in 36/46 (78%) patients, and
the baseline characteristics of patients with and without sig-
nificant improvement in LVEF are given in Table 1. Only
the functional LV parameters before revascularisation dif-
fered significantly between the groups. Patients in the non-
responder group had a significantly lower LVEF, greater LV
volume indexes and greater wall motion score indexes.
Overall, 333 (43%) of the 782 myocardial segments ana-
lysed had abnormal contractility and underwent success-
ful revascularisation. A functional recovery was observed
in 191 (57%) segments, but the remaining 142 segments
(43%) showed no signs of functional recovery after revas-
cularisation. The functional recovery of the myocardium
decreased with increasing LGE transmurality (82% seg-
ments with functional recovery in LGE 0% to 25%, 64%
in LGE 26% to 50%, 41% in LGE 51% to 75% and 13% in
LGE > 76% were found) (Figure 1). A similar trend in
segmental functional recovery was observed in 177 seg-
ments with severe hypokinesia, akinesia or dyskinesia
(89% segments with functional recovery in LGE 0% to
25%, 54% in LGE 26% to 50%, 38% in LGE 51% to 75%
and 10% in LGE > 76%) (Figure 1). Sixty-two per cent of
segments with functional recovery were observed in the
group with an end-diastolic wall diameter > 5.5 cm; how-
ever, only 41% of segments with an end-diastolic wall dia-
meter ≤ 5.5 cm recovered after revascularisation.
Prediction of myocardial regional functional recovery
after revascularisation using different CMR parameters
Based on segmental functional recovery, 6 months after
revascularisation, we calculated the prognostic value of
Table 1 The baseline characteristics of patients with and without significant improvement in LVEF
Baseline characteristics All patients
n=4 6
Responders
n=3 6
Non-responders
n=1 0
p value
Age (yrs) 63 ± 10 64 ± 10 60 ± 8 0.183
Female 5 5 0 0.570
GFR ml/min 91 ± 33 88 ± 34 101 ± 27 0.184
BSA (m
2) 2 ± 0.2 2 ± 0.3 2 ± 0.1 0.516
Hypertension 42 32 10 0.562
Diabetes mellitus 7 5 2 0.786
Previous documented MI 42 32 10 0.562
NYHA functional class 2.7 ± 0.8 2.6 ± 0.8 2.7 ± 1.0 0.634
CABG 34 26 8 0.512
ONBEAT 7 6 1 0.518
ONSTOP 27 20 7 0.518
Nr. of distal anastomoses 2.3 ± 1.6 2.2 ± 1.6 2.6 ± 1.6 0.422
LIMA 27 22 5 0.195
PCI 12 10 2 -
Beta-blocker 40 31 9 1.000
ACE inhibitor 33 27 6 0.351
Statin 37 28 9 0.389
Duration between revascularisation and follow-up CMR (weeks) 28 ± 4 28 ± 3 29 ± 8 0.704
LVEF (%) 35 ± 8 36 ± 8 32 ± 7 0.041
LVEF 30% or less 10 7 3 0.474
LV EDVI (ml/m
2) 95 ± 35 90 ± 35 114 ± 30 0.035
LV ESVI (ml/m
2) 62 ± 28 58 ± 28 77 ± 22 0.009
LV SI 0.56 ± 0.1 0.55 ± 0.1 0.6 ± 0.1 0.068
WMSI 1.9 ± 0.4 1.8 ± 0.4 2.2 ± 0.4 0.003
Total LGE score 1.0 ± 0.6 0.9 ± 0.6 1.2 ± 0.7 0.170
LGE mass (g) 31 ± 21 29 ± 21 36 ± 21 0.311
A responder was defined as a patient with an improvement in LVEF ≥ 5% after revascularisation. GFR, glomerular filtration rate; BSA, body surface area; MI,
myocardial infarction; CABG, coronary artery bypass graft surgery; ONBEAT, on-pump beating heart CABG; ONSTOP, conventional cardioplegic arrest CABG; LIMA,
left internal mammary artery; PCI, percutaneous coronary intervention; CMR, cardiovascular magnetic resonance; LVEF, left ventricular ejection fraction; EDVI, end-
diastolic volume index; ESVI, end-systolic volume index; LGE, late gadolinium enhancement; WMSI, wall motion score index; SI, sphericity index.
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LGE and the RIM that could be used in practice to dis-
tinguish between viable and nonviable segments (Table
2). We can clearly see that the sensitivities of the LGE
and the IR are comparable, but the specificity of the IR
is higher than the specificity of the LGE. The RIM spe-
cificity and sensitivity is slightly lower than the respec-
tive values for the IR.
To prospectively and directly compare the predictive
value of the IR, RIM and LGE, we used binary variables for
the LGE and the RIM (LGE50, 50% cut-off and RIM4, 4
mm cut-off). For a more detailed description of notations,
see the statistical analysis section. We compared the areas
under the ROC curves obtained using five different logistic
regression models (Figure 2). When the areas under the
ROC curves were compared, the combined viability predic-
tion model (LGE50 + IR) was superior to IR alone in all
analysed sets of segments except for segments with an LGE
from 26% to 75% (p = 0.08). The IR alone was statistically
significantly superior to the LGE50 alone in all the analysed
sets of segments (p = 0.0066 in all analysed segments and p
= 0.043 in segments with LGE from 26% to 75%).
Taking into account only the segments with any
degree of LGE (Figure 2B, C, D), the areas under the
ROC curves for IR alone, RIM4 alone and LGE50 +
RIM4 differed insignificantly. The AUC of the combined
(LGE50 + RIM4) model differed significantly from the
LGE50 alone model in all subsets of segments with any
degree of LGE; however, the areas under the ROC
curves of RIM4 alone and LGE50 alone were compar-
able in the segments with 26% to 75% and 1% to 75%
LGE (p = 0.15 and p = 0.18, respectively). A statistically
significant difference in the AUC between the two com-
bined models (LGE50 + IR and LGE50 + RIM4) was
observed, with the LGE50 + IR viability prediction
model being superior. There was no significant differ-
ence between IR alone and LGE alone in the segments
with LGE ≥ 76%.
Figure 1 Relationship between LGE before revascularisation and the likelihood of improved segmental contractility after
revascularisation. Data are shown for all 333 dysfunctional segments and separately for the 177 segments with at least severe hypokinesia
before revascularisation. For both analyses, there was an inverse relationship between the LGE and the likelihood of improvement in contractility.
Table 2 The prognostic value of the three different CMR viability parameters
Parameter Sensitivity (%) Specificity (%) PPV
(%)
NPV
(%)
Threshold
value
No. of analysed
segments
LGE 80 62 73 71 50% 333
RIM 77 72 69 80 4 mm 214
IR 80 78 83 75 - 333
The LGE and the RIM threshold values were calculated using the logistic regression model. PPV, positive predictive value; NPV, negative predictive value; no.,
number.
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diction parameters in patients with LVEF ≤ 30% and >
30%, IR was observed to be superior to LGE50 in the
group with LVEF > 30% (p < 0.00001) but not in the
group with LVEF ≤ 30% (p = 0.29). The same significant
superiority of the combined viability prediction model
(LGE50 + IR) over the IR only model was noticed in
both patient groups. In patients with LVEF ≤ 30%, using
the combined viability prediction model (LGE50 + IR),
the percentage of correct predictions for hibernating
Figure 2 ROC curves: the logistic regression model combining LGE50 and IR compared to IR alone and LGE50 alone. The AUC value for
LGE50 + IR was significantly higher than IR alone or LGE50 alone in all analysed segments (A); the AUC value for LGE50 + IR was significantly
higher than IR alone or LGE50 alone in the segments containing any degree of LGE (B); the AUC value for LGE50 + IR differs insignificantly from
the IR alone in the segments with 26% to 75% LGE (C); and the difference between LGE50 + IR and IR alone is significant in segments with 1%
to 75% LGE (D).
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with LVEF > 30%.
Prediction of global left ventricular functional recovery
after revascularisation
Overall, the mean improvement in global ventricular
function 6 months after revascularisation was 11 ± 7%.
In the group with significant LVEF improvement, the
mean NYHA functional class was improved by 1 class,
whereas in the group without significant LVEF improve-
ment, the mean NYHA functional class remained
unchanged. At follow-up, none of the patients had
angina pectoris of more than class I CCS.
There was a strong inverse correlation between the
baseline WMSI and LVEF 6 months after revascularisa-
tion (r = -0.75, p < 0.0001); however, the correlation
between the mass of LGE to LVEF change and the cor-
relation between the mass of LGE and the LVEF after
revascularisation was weak (r = -0.35 and r = -0.39,
respectively). Interestingly, we found an excellent corre-
lation between LVEF measured during administration of
dobutamine (10 μg/kg/min) and LVEF 6 months after
revascularisation (Figure 3).
Six months after revascularisation, we observed a sig-
nificant difference between the responder and nonre-
sponder groups in LVEF (50 ± 11% vs. 33 ± 6%,
respectively, p < 0.001) and LV sphericity index (0.5 ±
0.1 vs. 0.6 ± 0.1, respectively, p = 0.048) and a border-
line significant difference in the number of segments
with functional recovery (4.4 ± 2.6 vs. 2.9 ± 2.1, respec-
tively, p = 0.077). Taking into account the changes of
LV functional parameters within each group, both
groups demonstrated significant improvement in WMSI;
however, a significant improvement of ESVI at follow-
up was observed only in the responder group (Table 3).
Changes in the other LV parameters (i.e., mitral valve
regurgitation fraction, EDVI and sphericity index) after
revascularisation were insignificant in both groups.
To assess the best CMR-based predictors of significant
LVEF improvement, we used variables that differed sig-
nificantly between the responders and nonresponders at
baseline (Table 1). Using forward stepwise logistic analy-
sis, we found that EDVI (p = 0.79), ESVI (p = 0.76) and
WMSI (p = 0.26) are not good predictors of significant
LVEF improvement.
Additionally, we compared two other parameters: the
absolute number of viable segments in a patient and the
percentage of viable segments from all dysfunctional
and revascularised segments in a patient. A viable seg-
ment was defined as a segment without any LGE or
with any LGE and having IR during LDD-CMR. The
relationship between the percentage of viable segments
and the change in LVEF was relatively close to linear
(Figure 4). Using ROC analysis, the AUC for the percen-
tage of viable segments was 0.7 (p = 0.05) compared to
AUC 0.52 for the number of viable segments (p = 0.94)
(Figure 5). This finding shows that the absolute number
of viable segments is inferior to the percentage of viable
segments for predicting significant LVEF improvement.
An additional ROC analysis was used to define a thresh-
o l df o rt h ep e r c e n t a g eo fv i a b l es e g m e n t si nap a t i e n t
that had the optimal sensitivity and specificity for pre-
dicting global function recovery. The application of a
cut-off value of ≥ 50% viable segments yielded a 69%
sensitivity and a 70% specificity (AUC 0.7, p = 0.054). A
cut-off of 3 viable segments produced lower diagnostic
value, with a sensitivity of 78% and a specificity of 40%.
Discussion
Prediction of regional functional recovery
The decreasing likelihood of functional recovery with
more extensive scarring found in the present study con-
firms the prognostic importance of scarred myocardium,
which is consistent with previous studies [7-9]. The high
Figure 3 Correlation between LVEF measured during LDD
administration and LVEF 6 months after revascularisation.
Table 3 The dynamic changes in LV function after
revascularisation within groups of patients with and
without significant improvement in LVEF
Responders Baseline Follow-up Mean diff. ± SD p value
EDVI 90 ± 35 88 ± 24 2.1 ± 26 0.326
ESVI 58 ± 28 46 ± 21 12 ± 13 <0.001
EF (%) 36 ± 8 50 ± 11 14 ± 6 <0.001
WMSI 1.8 ± 0.4 1.5 ± 0.4 0.3 ± 0.3 <0.001
Non-responders
EDVI 114 ± 30 111 ± 26 3.0 ± 29 0.492
ESVI 77 ± 22 74 ± 19 3.0 ± 20 0.557
EF (%) 32 ± 7 33 ± 6 1.4 ± 2.4 0.105
WMSI 2.2 ± 0.4 2.0 ± 0.4 0.2 ± 0.2 0.020
Same abbreviations as used in Table 1.
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ring (LGE ≤ 25%) in our cohort recovered 6 months
after revascularisation, which agrees with results of pre-
vious studies conducted by Selvanayagam et al. [15] and
Bondarenko et al. [16]. The high percentage of recov-
ered segments in our cohort confirms that a 6-months
post-revascularisation period was sufficient for almost
complete recovery.
Using an LGE threshold value of 50%, we can roughly
differentiate patients in whom recovery of regional
myocardial function is likely or unlikely, with a sensitiv-
ity of 80% and a specificity of 62%. An RIM value of 4
mm can predict the recovery of hibernating myocardium
with a sensitivity and specificity of approximately 77%
and 72%, respectively. Although the sensitivities of LGE
50 and IR are comparable, the IR specificity is higher
(78%), which is consistent with previous studies [8].
Additionally, comparing the areas under the ROC
curves, we found that IR alone is statistically signifi-
cantly superior to LGE50 alone in predicting segmental
functional recovery in all analysed sets of segments. The
latter finding does not contradict the findings of a pre-
vious study conducted by Wellnhofer et al. [8]. Interest-
ingly, the combined viability prediction model (LGE50 +
IR) was significantly better than IR alone in all analysed
subsets of segments, except in segments with LGE from
26% to 75%. These results confirm the large advantage
of LDD-CMR versus LGE-CMR in segments with 26%
to 75% LGE. In patients with an intermediate LGE from
1% to 75% and from 26% to 75%, the addition of the IR
improved the correct predictions of the hibernating
myocardium from 65% to 76% and from 63% to 76%,
respectively.
In ischemic cardiomyopathy with regional wall thin-
ning, the addition of RIM measures to LGE can be use-
ful, but according to our findings, the RIM did not give
much more information than LGE, especially in seg-
ments with LGE from 1% to 75% or from 26% to 75%.
As we expected, the correlation coefficient between the
RIM and LGE is high (r = -0.81), and the AUC values
are comparable because these two parameters carry vir-
tually the same information regarding scar transmural-
ity. In contrary, a study conducted by Ichikawa et al.
[17] confirmed that the thickness measurement of none-
nhanced myocardium, compared with measurement of
LGE per cent, possessed better diagnostic accuracy for
predicting improved systolic wall thickening from acute
to chronic MI state in dysfunctional segments. The lat-
ter findings cannot be directly compared to our findings
because [17] their study focused on a stunned and
timely reperfused myocardium in patients with relatively
preserved LV function, whereas our study focused on
hibernated and revascularised myocardium in patients
with moderately to severe LV function impairment.
Additionally, a study conducted by Kirschbaum et al.
[11] confirmed that the baseline function of the unen-
hanced myocardial rim is more important than the rim
thickness in predicting the presence of inotropic reserve
in segments with intermediate LGE. Our findings con-
firm the fact that in segments with intermediate LGE,
functional assessment of the RIM (i.e., assessment of the
inotropic reserve during LDD) is more important than
measuring RIM thickness. Thus, it is possible to assess
the inotropic reserve during LDD or to measure the
Figure 4 Correlation between the percentage of viable
segments and the change in LVEF 6 months after
revascularisation. *Percentage of viable segments is defined as the
number of viable segments in a patient divided by all dysfunctional
and revascularised segments and is expressed as a percentage.
Figure 5 The areas under the ROC curves for the percentage
of viable segments and the number of viable segments for
predicting significant improvement in global LV function after
revascularisation. Definitions of the terms are in the text.
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formed in [11]) in segments with intermediate LGE, but
further studies directly comparing these two approaches
as predictors of functional recovery after revascularisa-
tions are needed.
Interestingly, the IR alone model and the combined
viability prediction model (LGE50 + RIM4) differed
insignificantly in segments with any degree of contrast
enhancement, especially in segment subsets with LGE 1-
75% and 26-75%; however, the LGE50 + IR model was
significantly superior to the LGE50 + RIM4 model. This
suggests that the additional value of IR assessment is
greater than that of RIM4 in segments with intermediate
LGE.
The results of the aforementioned analysis indicate
that the addition of LDD-CMR to LGE-CMR improves
viability prediction when all dysfunctional segments,
including and excluding those without any contrast
enhancement, are analysed. IR is superior to LGE50 in
predicting hibernating myocardium in all sets of seg-
ments. Taking into account the fact that most of the
segments (approximately 82%) with LGE ≤ 25% recover
a n dt h a tm o s to ft h es e g m e n t s( a p p r o x i m a t e l y8 7 % )
with LGE ≥ 76% do not recover function after revascu-
larisation, the evaluation of additional viability para-
meters besides LGE seems to have little additional value
in this subset of segments. Thus, the addition of LDD-
CMR seems to have the biggest additional value in seg-
ments with 26% to 75% LGE, whereas measuring of the
RIM thickness has no superiority over LGE50 in this
LGE subset.
The high percentage (79%) of correct predictions for
hibernating myocardium in the patient group with EF ≤
30% confirms the hypothesis that CMR is very suitable
for viability prediction, especially in patients with severe
LV dysfunction, in whom echocardiographic methods of
viability prediction are less accurate [18].
Taking into account the higher predictive value of IR
compared with LGE50, it is possible to use LDD-CMR
instead of LGE-CMR to assess viability in selected
patients with severely reduced renal function (GFR <30
ml/min) to avoid the risk of nephrogenic systemic
fibrosis.
Prediction of global functional recovery
We found an excellent correlation between LVEF during
LDD and LVEF 6 months after revascularisation (r =
0.85, p < 0.0001). This suggests that by measuring LVEF
by CMR during LDD administration, it is possible to
predict the absolute LVEF 6 months after successful
revascularisation.
At baseline, we observed significant differences
between the groups with and without significant LVEF
improvement regarding LV volume indexes, WMSI and
LVEF. Patients in the nonresponder group had more
remodelled left ventricles at baseline, lower LVEF,
higher LV volume indexes and higher WMSI. These
baseline factors could contribute to the fact that the 6-
month follow-up period could be too short for signifi-
cant inverse remodelling in such ventricles. We
observed insignificant changes in the LV volume index,
sphericity index and WMSI at follow-up. However,
patients in the responder group showed a trend to
inverse remodelling of the LV. They experienced a sig-
nificant decrease in ESVI and WMSI and a marked
increase in LVEF.
Previous studies have demonstrated that a substantial
amount of the jeopardised myocardium needs to be pre-
sent to result in an improvement of LVEF after revascu-
larisation. In previous studies, the setting of a cut-off
level of ≥ 4 dysfunctional and viable segments (repre-
senting approximately 25% of the left ventricle) assessed
by echocardiography yielded the highest diagnostic accu-
racy to predict improvement in LVEF [19,20]. The pre-
sent study demonstrates that the absolute number of
viable segments has a lower predictive value for global
LV functional recovery than the percentage of viable
segments. The weak predictive value of the number of
viable segments was recently reported by other investi-
gators (i.e., Pegg et al.) [21]. As we were basing our
experiments on a different study design and relying on
our segmental functional recovery prediction results, we
incorporated LGE-CMR and LDD-CMR data. Our
results concerning global functional recovery prediction
indicate that the best predictor of significant LVEF
improvement 6 months after revascularisation in our
cohort was the percentage of viable segments from all
dysfunctional and revascularised segments in a patient.
The cut-off value ≥ 50% predicts significant LVEF
improvement with 69% sensitivity and 70% specificity
(AUC 0.70, p = 0.054). Although the p-value is of bor-
derline significance, we think that the value could be
influenced by the small sample size, especially in the
nonresponder group. The predictor of global functional
recovery in our study had a lower predictive value than
the predictor used in a study conducted by Pegg et al.
[20]; this could be explained by a different definition of
significant LVEF improvement (i.e., ≥ 3% change in EF
[20] versus ≥ 5% change in our cohort). Further studies
are warranted to confirm our findings. However, these
findings could be relevant for clinicians making deci-
sions regarding revascularisation in patients with
impaired LV function in everyday practice. Our findings
and the results of the study conducted by Pegg et al.
[21] raise questions regarding the definition of substan-
tial myocardial viability in further clinical viability stu-
dies. The above-mentioned STICH viability substudy
failed to demonstrate a significant interaction between
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treatment with respect to the mortality or the rate of
death or hospitalisation for cardiovascular causes. The
primary reason for this failure was that the absolute
number of viable segments was used in the STICH trial
instead of other, more sophisticated definitions of sub-
stantial amount of viable myocardium (e.g., percentage
of viable segments, as in present study).
Clinical implications
For clinical use, we propose to initially perform LGE-
CMR and add the LDD-CMR just after the LGE-CMR
only in patients with LGE from 1% to 75%, as the addi-
tion of LDD significantly improves viability prediction in
this subset of patients. The measurement of RIM thick-
ness in the segments with any degree of LGE does not
give more information than LGE. Revascularisation, in
cases when patients have no angina pectoris and the tar-
get is the improvement of heart failure symptoms,
should be performed when there is a substantial amount
of viable myocardium, (50% or more viable segments
from all dysfunctional and revascularised segments).
Limitations
The major limitation of present study is the small sam-
ple size. However, this sample size is comparable to pre-
viously published studies that used LGE-CMR and
LDD-CMR in patients with chronic ischemic heart dis-
ease undergoing revascularisation [8,9,11]. In our study,
the verification of functional recovery was performed at
6 months after revascularisation, and this time period
seemed sufficiently late in view of the high percentages
of correct predictions. However, the use of a single eva-
luation for ventricular function in the short period after
revascularisation may lead to an underestimation of the
true rate of functional recovery because the time course
of full recovery may be up to 24 ± 12 months [16].
However, with a longer follow-up period, LV function
could be strongly influenced by late graft failure or stent
restenosis [16]. Even if technically successful, coronary
revascularisation may be incomplete, particularly in
patients with extensive atherosclerosis and diffuse dis-
ease. Although restenosis/graft occlusion was excluded
through invasive procedures in nine patients (20%), their
non-invasive follow-up revealed that they were free of
symptoms or signs indicating recurrent ischemia or
major adverse cardiac events. Not one patient from our
study group manifested any new wall motion abnormal-
ities at follow-up. Furthermore, myocardial segments
with new LGE zones, which were observed in 7 patients,
were excluded from the analysis. The visual assessment
of wall motion is also a limitation of the present study.
A quantitative assessment of intramyocardial deforma-
tion or strain during LDD-CMR with rapid post-
processing algorithms is a promising technique for the
more accurate prediction of functional recovery, but
future studies are needed before inclusion of these tech-
niques into routine clinical practice.
Conclusions
LGE-CMR and LDD-CMR provide complementary
information regarding myocardial viability, and a combi-
nation of both techniques is valuable for a more accu-
rate prediction of viability. LDD-CMR is superior to
LGE-CMR as a predictor of segmental functional recov-
ery and does not depend on the transmurality of the
scar. In segments with an LGE from 26% to 75%, LDD-
CMR is not inferior to the combination of LDD-CMR
and LGE-CMR; thus, the greatest advantage of IR is in
segments with LGE from 26% to 75%. The RIM did not
give much more information than LGE. When defining
viability as the absence of LGE or the presence of IR in
the case of any degree of LGE, patients with ≥ 50% of
viable segments from all dysfunctional and revascu-
larised segments have a tendency to improve LVEF ≥
5% after revascularisation. There are trends towards LV
reverse remodelling in the group with significant LVEF
improvement after revascularisation. By measuring
LVEF during LDD administration, it is possible to pre-
dict the absolute value of LVEF 6 months after
revascularisation.
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